23 September 2020 : Clinical Research
A Study on the Predictors of Disease Severity of COVID-19
Liang Li1ABCDE, Wei Sun1ABCD, Mingfeng Han1BCD, Yunli Ying1CDEF, Quanzhi Wang2AFG*DOI: 10.12659/MSM.927167
Med Sci Monit 2020; 26:e927167
Table 5 Laboratory indices of COVID-19 patients in the severe group and nonsevere group.
| Items | Total | Severe group | No-severe group | Statistics | P-value |
|---|---|---|---|---|---|
| WBC (×10/L) | 5.41±2.11 | 5.32±2.30 | 5.43±2.07 | 0.258# | 0.797 |
| lymphocytes(×10/L) | 1.17±0.63 | 0.88±0.35 | 1.24±0.66 | 2.917# | 0.014 |
| ALT (U/L) | 24.00 (14.00, 37.25) | 27.00 (20.25, 39) | 23.00 (13.00, 37.00) | 1551.00* | 0.102 |
| AST (U/L) | 26.00 (20.00, 33.25) | 29.50 (26.00, 39.75) | 25.00 (19.00, 33.00) | 1235.00* | 0.002 |
| C-reactive protein (mg/L) | 12.50 (2.68, 33.55) | 49.70 (20.53, 85.95) | 7.95 (1.83, 23.28) | 730.00* | <0.001 |
| Data were shown as mean±standard deviation, median (Q1, Q3). * value; # test; WBC – white blood cell; ALT – alanine aminotransferase; AST – aspartate aminotransferase. | |||||